Alcon AG | ALC - Przychody Ze Sprzedaży





Obroty Zmiana Data
AstraZeneca USD 15.29B 213M 2026-03
Bayer EUR 13.41B 1.97B 2026-03
Essilor EUR 14.47B 7.6B 2025-12
Fresenius EUR 5.74B 140M 2026-03
Fresenius Medical Care EUR 4.61B 460M 2026-03
GlaxoSmithKline GBP 7.63B 991M 2026-03
GRIFOLS EUR 1.7B 280M 2026-03
Lonza CHF 3.58B 63M 2025-06
Merck EUR 5.13B 120M 2026-03
Novartis USD 13.11B 226M 2026-03
Philips EUR 3.91B 1.19B 2026-03
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 11.24B 60M 2026-03
Smith & Nephew USD 3.18B 353M 2025-12
Sonova Holding CHF 1.82B 216.8M 2025-12
UCB EUR 4.25B 764M 2025-12